-transparent.png){kind=logo}
The dexamethasone suppression test (DST) as now commonly carried out in psychiatric settings yields "abnormal" results in many conditions including the healthy state. To determine whether the DST accurately identifies patients with physiologically meaningful increases in pituitary-adrenocortical activity, we compared DST results to baseline urinary cortisol level. Thirty-four psychiatric inpatients underwent a 24-hour urine collection and then a DST using 1 or 2 mg of dexamethasone. With the common 1-mg DST, 24-hour urinary cortisol levels in nonsuppressors and suppressors did not differ. With the 2-mg DST, however, nonsuppressors had significantly higher urinary cortisol levels than suppressors, and all nonsuppressors had urinary cortisol levels above the normal range. Thus, the 1-mg DST may not identify the heuristically important subgroup of psychiatric patients who have a pathophysiologically meaningful alteration in pituitary-adrenal regulation.
W A Brown, and
G Keitner, and
C B Qualls, and
R Haier
June 1982,
Clinical chemistry,
W A Brown, and
G Keitner, and
C B Qualls, and
R Haier
February 1966,
Chinese medical journal (Peking, China : 1932),
W A Brown, and
G Keitner, and
C B Qualls, and
R Haier
December 1968,
Nihon Naibunpi Gakkai zasshi,
W A Brown, and
G Keitner, and
C B Qualls, and
R Haier
March 1984,
Chemical & pharmaceutical bulletin,
W A Brown, and
G Keitner, and
C B Qualls, and
R Haier
February 1984,
Obstetrics and gynecology,
W A Brown, and
G Keitner, and
C B Qualls, and
R Haier
November 1994,
Clinical endocrinology,
W A Brown, and
G Keitner, and
C B Qualls, and
R Haier
December 1987,
The Japanese journal of psychiatry and neurology,
W A Brown, and
G Keitner, and
C B Qualls, and
R Haier
January 1984,
The American journal of psychiatry,
W A Brown, and
G Keitner, and
C B Qualls, and
R Haier
May 1998,
Biological psychiatry,
W A Brown, and
G Keitner, and
C B Qualls, and
R Haier
March 1982,
The Journal of clinical endocrinology and metabolism,
